HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aspalathin improves hyperglycemia and glucose intolerance in obese diabetic ob/ob mice.

AbstractPURPOSE:
Although several researches have demonstrated that rooibos extract has hypoglycemic effect, the role of aspalathin, a main polyphenol in the extract, remains unclear. Our aims were to find specific mechanisms for anti-diabetic action of aspalathin employing a rat skeletal muscle-derived cell line (L6 myocytes) and a rat-derived pancreatic β-cell line (RIN-5F cells) and to investigate its effect in type 2 diabetic model ob/ob mice.
METHODS:
We investigated in vitro the effect of aspalathin on the glucose metabolism through the studies on molecular mechanisms of glucose uptake using cultured L6 myotubes. We also measured the antioxidative ability of aspalathin against reactive oxygen species (ROS) generated by artificial advanced glycation end product (AGE) in RIN-5F cells. In vivo, ob/ob mice were fed 0.1 % aspalathin-containing diet for 5 weeks, and the effect of aspalathin on fasting blood glucose level, glucose intolerance, and hepatic gene expression was studied.
RESULTS:
Aspalathin dose dependently increased glucose uptake by L6 myotubes and promoted AMP-activated protein kinase (AMPK) phosphorylation. Aspalathin enhanced GLUT4 translocation to plasma membrane in L6 myoblasts and myotubes. In RIN-5F cells, aspalathin suppressed AGE-induced rises in ROS. In vivo, aspalathin significantly suppressed the increase in fasting blood glucose levels and improved glucose intolerance. Furthermore, aspalathin decreased expression of hepatic genes related to gluconeogenesis and lipogenesis.
CONCLUSIONS:
Hypoglycemic effect of aspalathin is related to increased GLUT4 translocation to plasma membrane via AMPK activation. In addition, aspalathin reduces the gene expression of hepatic enzymes related to glucose production and lipogenesis. These results strongly suggest that aspalathin has anti-diabetic potential.
AuthorsMyoung Jin Son, Miki Minakawa, Yutaka Miura, Kazumi Yagasaki
JournalEuropean journal of nutrition (Eur J Nutr) Vol. 52 Issue 6 Pg. 1607-19 (Sep 2013) ISSN: 1436-6215 [Electronic] Germany
PMID23238530 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adiponectin
  • Blood Glucose
  • Chalcones
  • Glucose Transporter Type 4
  • Hypoglycemic Agents
  • Insulin
  • Leptin
  • Reactive Oxygen Species
  • aspalathin
  • Cholesterol
  • AMP-Activated Protein Kinases
Topics
  • AMP-Activated Protein Kinases (genetics, metabolism)
  • Adiponectin (blood)
  • Animals
  • Blood Glucose (drug effects, metabolism)
  • Body Weight
  • Cell Line
  • Chalcones (pharmacology)
  • Cholesterol (blood)
  • Diabetes Mellitus, Experimental (drug therapy, metabolism)
  • Gluconeogenesis (drug effects)
  • Glucose Intolerance (drug therapy)
  • Glucose Transporter Type 4 (genetics, metabolism)
  • Glycogenolysis (drug effects)
  • Hyperglycemia (drug therapy)
  • Hypoglycemic Agents
  • Insulin (blood)
  • Insulin-Secreting Cells (drug effects, metabolism)
  • Leptin (blood)
  • Lipogenesis (drug effects)
  • Mice
  • Mice, Obese
  • Muscle Fibers, Skeletal (drug effects, metabolism)
  • Muscle, Skeletal (cytology, drug effects)
  • Phosphorylation
  • Rats
  • Reactive Oxygen Species (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: